While hardware revenue is continuing to decline - 58% to $42.4 million in Q3/24 - revenue ... and also in comparison to Medtronic's Guardian. Now we could argue that Dexcom might be able to ...

The global injection pen market is poised for significant growth, with projections indicating a robust compound annual growth rate (CAGR) of 7.0% from 2022 to 2033. The market is expected to escalate ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

GALWAY, Ireland, Nov. 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of ...

Shares of Medtronic PLC MDT inched 0.41% higher to $89.68 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.23% to ...

Separately, Medtronic Inc. announced plans to temporarily lay off 237 workers at its Santa Ana business unit by Dec. 4, according to an EDD filing. In an emailed statement, Medtronic spokeswoman ...

Medtronic has issued a second alert letter to ... The new alert updates a previous one issued in July. On October 4, 2024 (and announced by FDA on October 17), the company issued an “Urgent ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelect™ Pulsed Field Ablation System, which was FDA approved ...

Shares of Medtronic PLC MDT sank 0.22% to $89.79 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.37% to ...